Shares of Novavax, Inc. (NVAX) plunged over 19.5% on Thursday after Health and Human Services Secretary Robert F. Kennedy Jr.

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

The Novavax shot is already available under emergency use. But full FDA approval would allow the vaccine to be used more widely and could offer more reassurance to people looking for options ...

The vaccine remains available under the emergency use authorization ... senior officials laid off were involved in the review of Novavax's vaccine. But reports that vaccine decisions are being ...

Full approval would make the vaccine available beyond an emergency declaration ... and we believe that our is ready for approval," Novavax said in a statement, noting that the application ...

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...